NYSE:USNAPersonal Products
Usana Health Sciences Q1 Profit Rebound Tests Persistent Margin Concerns Narratives
USANA Health Sciences (USNA) opened 2026 with Q1 revenue of US$250.2 million and basic EPS of US$0.41, setting a clear marker against a share price of US$20.01. The company has seen quarterly revenue range from US$213.6 million in Q4 2024 to US$250.2 million in Q1 2026, while basic EPS over that stretch has moved between a loss of US$0.36 in Q3 2025 and a gain of US$0.52 in Q2 2025. This leaves investors focused on how consistently the latest margin profile can be sustained from here.
See our...